An Observational Study of the Use of Chloral Hydrate for Ophthalmic Procedures in Children
1 other identifier
observational
324
1 country
1
Brief Summary
The study involves a prospective evaluation of chloral hydrate sedation for the measurement of intraocular pressure in children ages one month to five years of age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 30, 2016
CompletedFirst Posted
Study publicly available on registry
December 7, 2016
CompletedDecember 7, 2016
December 1, 2016
3.2 years
November 30, 2016
December 5, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Change in intraocular pressure during chloral hydrate sedation
Unit- mmHg
25 minutes after sedation to 125 minutes after sedation
Secondary Outcomes (6)
Chloral hydrate dose required for successful sedation
Adminstration to adequate sedation (up to 30 minutes)
Time to recovery
Sedation induction to 125 minutes after sedation
Hear rate under sedation
Sedation induction to 125 minutes after sedation
Blood pressure under sedation
Sedation induction to 125 minutes after sedation
Oxygen saturation under sedation
Sedation induction to 125 minutes after sedation
- +1 more secondary outcomes
Study Arms (2)
Intraocular pressure evaluation
Intraocular pressure evaluation using Icare tonometer 25 minutes after sedation, and then every 10 minutes until sedation is complete
Safety of sedation
Documentation of: 1. The need for repeat dosing of chloral hydrate. 2. The level of alertness of the patient at the end of sedation and the total time between induction and readiness for discharge 3. Interventions required for the patient including administration of oxygen, and need for intubation.
Interventions
Intraocular pressure checked with Icare rebound tonometer at 25 minutes after induction, followed by every 10 minutes until sedation was complete.
Eligibility Criteria
Children aged 1 month to five years requiring sedation for ophthalmic care at King Khaled Eye Specialist Hospital (KKESH).
You may qualify if:
- ages 1 month to five years
- require sedation for ophthalmic care
You may not qualify if:
- weight \<3 kg or \>20 kg
- infection/ocular surface disease
- medical contraindication of chloral hydrate
- green or gray nasal discharge
- fever, productive cough, chest retractions, or other signs of respiratory infection
- oxygen saturation \< 90%
- active infectious disease such as rubella or varicella
- rectal or tympanic temperature \> 37.7 degrees, or oral or temporal artery temperature \> 37.2 degrees
- history of current ongoing vomiting and diarrhea
- anemia (Hgb \< 9.0mg),
- history of seizure in past 6 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- King Khaled Eye Specialist Hospitalcollaborator
Study Sites (1)
King Khaled Eye Specialist Hospital (KKESH)
Riyadh, Riyadh Region, 12329, Saudi Arabia
Related Publications (2)
Vade A, Sukhani R, Dolenga M, Habisohn-Schuck C. Chloral hydrate sedation of children undergoing CT and MR imaging: safety as judged by American Academy of Pediatrics guidelines. AJR Am J Roentgenol. 1995 Oct;165(4):905-9. doi: 10.2214/ajr.165.4.7676990.
PMID: 7676990BACKGROUNDLitman RS, Soin K, Salam A. Chloral hydrate sedation in term and preterm infants: an analysis of efficacy and complications. Anesth Analg. 2010 Mar 1;110(3):739-46. doi: 10.1213/ANE.0b013e3181ca12a8. Epub 2009 Dec 23.
PMID: 20032023BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
David S Friedman, MD, MPH, PhD
Johns Hopkins University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 30, 2016
First Posted
December 7, 2016
Study Start
September 1, 2013
Primary Completion
November 1, 2016
Study Completion
November 1, 2016
Last Updated
December 7, 2016
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share